http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105342990-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 |
| filingDate | 2015-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105342990-B |
| titleOfInvention | Eye drops containing moxifloxacin hydrochloride and dexamethasone and preparation method thereof |
| abstract | The invention belongs to the technical field of medicines, and particularly relates to eye drops containing moxifloxacin hydrochloride and dexamethasone and a preparation method thereof, wherein the eye drops comprise the following components: 0.5 wt% of moxifloxacin hydrochloride, 0.05-0.2 wt% of dexamethasone, 0.5 wt% of isotonic regulator, 0.01 wt% of surfactant, pH regulator and water, wherein the addition amount of the pH regulator is used for ensuring that the pH value of the composition is 6.0-8.0. The eye drop containing moxifloxacin hydrochloride and dexamethasone and the preparation method thereof have the characteristics of high efficiency, low toxicity, wide antibacterial spectrum, good stability and high safety degree, and can effectively treat ocular inflammation. |
| priorityDate | 2015-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.